Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine without Adjuvant Drug Information [ ID Biomedical Corporation ]
Table of content
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine without Adjuvant category:
Active ingredients:
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine without Adjuvant companies and manufacturers:
General Information
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine without Adjuvant forms, composition and dosages:
- Suspension; Intramuscular; Haemagglutinin A / Californina / 7 / 2009 (H1N1) V-Like Strain (X-179A) 15 mcg / 0.5 ml
Indications, usages and classification codes:
- J07BB02 - Influenza, Purified Antigen
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Adenovirus Vaccine Live Oral Type 7 Wyeth
- Adiugrip Sanofi-Aventis
- Afluria ZLB Behring
- Aggripal S1 Novartis
- Agrippal Novartis; Allphar Services; Berk Ilac Ithalat ve Pazarlama; Biogenetech; Biovac; Chiron; Concept for Pharmacy; Elea Laboratorio; Gerolymatos; IDS Hong Kong; IVAX; Meda; Medicom International; Wyeth
- Alorbat Baxter; Viatris
- Ambirix GlaxoSmithKline
- Avaxim Sanofi-Aventis; Merck; ProMedico; Zuellig Pharma
- Avaxim Pediatric Sanofi-Aventis
- Batrevac Solvay; SBL Vaccin
- BCG Therapeutic Connaught Laboratories
- BCG Vaccine ID Biomedical Corporation
- BCG Vaccine Sanofi-Aventis
- BCG Vaccine SSI Statens Serum Institut
- BCG Vaccine, freeze-dried Sanofi-Aventis
- Begrivac Wyeth; Chiron; Grunenthal; Meda; Multichem, New Zealand; Novartis; Orphan Pharmaceutical
- Berigripina Elea Laboratorio
- Biaflu Kedrion
- Biaflu-Zonale SU Kedrion
- Buccapol Edward Keller; Diethelm; F. Joh. Kwizda
